Aiello et al., “Suppression of retinal neovascularization in vivo by inhibition . . . ”, Proc. Natl. Acad. Sci. USA 92:10457-10461, 1995. |
Boocock et al., “Expression of Vascular Endothelial Growth Factor and Its Receptors . . . ”, Journal of the National Cancer Institute 87:506-516, 1995. |
Gengrinovitch et al., “Platelet Factor—4 Inhibits the Mitogenic Activity of VEGF121 and . . . ”, J. Biol. Chem. 270:15059-15065, 1995. |
Kendall et al., “Inhibition of vascular endothelial cell growth factor activity by an . . . ”, Proc. Natl. Acad. Sci. USA 90:10705-10709, 1993. |
Kendall et al., “Specificity of vascular endothelial cell growth factor receptor ligand . . . ”, Biochemical and Biophysical Research Communications 201:326-330, 1994. |
Wang et al., “Identification of the Ligand-Binding Regions in the Macrophage Colony . . . ”,Molecular and Cellular Biology, 13:5348-5359, 1993. |
Hollenbaugh et al., Current Protocols in Immunology, Unit 10,19, 1992. “Construction of Immunoglobulin Fusion Proteins”.* |
M. Shibuya et al., “Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (fit) closely related to the fms family”, Oncogene 5:519-524,1990. |